1JMO | Blood Clotting | date | Jul 19, 2001 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of The Heparin Cofactor II-S195a Thrombin Complex | ||||||||||||||
authors | T.P.Baglin, R.W.Carrell, F.C.Church, C.T.Esmon, J.A.Huntington | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Thrombin, Light Chain Chain: L Fragment: Light Chain Synonym: Coagulation Factor II Engineered: Yes Other_details: Contains Extra 13 Amino Acids At The N- Terminus; |
Organism_scientific: Homo Sapiens Organism_common: Human Expression_system: Cricetulus Griseus Expression_system_common: Chinese Hamster Expression_system_cell_line: Bhk Culture Expression_system_organ: Kidney | ||||||||||||||
Molecule: Thrombin, Heavy Chain Chain: H Fragment: Heavy Chain Synonym: Coagulation Factor II Ec: 3.4.21.5 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Expression_system: Cricetulus Griseus Expression_system_common: Chinese Hamster Expression_system_cell_line: Bhk Culture Expression_system_organ: Kidney | ||||||||||||||
Molecule: Heparin Cofactor II Chain: A Synonym: Hc-II; Protease Inhibitor Leuserpin 2; Hls2 Serine (Or Cysteine) Proteinase Inhibitor, Clade D (Heparin Cofactor), Member 1 |
Organism_scientific: Homo Sapiens Organism_common: Human Other_details: Plasma Purified Human Heparin Cofactor II | ||||||||||||||
symmetry | Space Group: P 61 | R_factor | 0.205 | ||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 Å | ||||||||||||
ligand | STY, NAG, MPD | enzyme | Thrombin. Fibrinogenase. Thrombase. Thrombofort. Topical. Thrombin-C. Tropostasin. Activated blood-coagulation factor II. Blood-coagulation factor IIa. Factor IIa. E thrombin. Beta-thrombin. Gamma-thrombin. Hydrolase E.C.3.4.21.5 | ||||||||||||
note | 1JMO is a representative structure | ||||||||||||||
related structures | by homologous chain: 1JMJ, 1NU7, 1QHR | ||||||||||||||
domain | The n-terminal acidic repeat region mediates, in part, the glycosaminoglycan-accelerated thrombin inhibition. | ||||||||||||||
similarity | Contains 2 kringle domains. Belongs to peptidase family s1. Belongs to the serpin family.[trypsin] | ||||||||||||||
catalytic activ. | Preferential cleavage fibrinogen to fibrin and releases fibrinopeptide a and b. | ||||||||||||||
post-translat. modifications | The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin k-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin. | ||||||||||||||
tissue | Expressed predominantly in liver. Expressed by the liver and secreted in plasma. | ||||||||||||||
subcellular loc. | Extracellular. | ||||||||||||||
genes | F2 (B. taurus); B2209, ECO, ETI (E. coli); F2, HCF2, SERPIND1, THBD, THRM (H. sapiens) | ||||||||||||||
function | Thrombin, which cleaves bonds after arg and lys, converts fibrinogen to fibrin and activates factors v, vii, viii, xiii, and, in complex with thrombomodulin, protein c. Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner. In the presence of the latter, hc-ii becomes the predominant thrombin inhibitor in place of antithrombin iii (at-iii). Peptides at the n-terminal of hc-ii have chemotactic activity for both monocytes and neutrophils. Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. | ||||||||||||||
Gene Ontology | chain A: GO:0004866, GO:0004867, GO:0005576, GO:0006935, GO:0007596, GO:0008201 chain H: GO:0000074, GO:0003809, GO:0004252, GO:0004263, GO:0004295, GO:0005102, GO:0005509, GO:0005576, GO:0005615, GO:0005625, GO:0006508, GO:0006915, GO:0006919, GO:0006953, GO:0007260, GO:0007262, GO:0007275, GO:0007596, GO:0008236, GO:0009611, GO:0016787, GO:0030168, GO:0030193, GO:0042730 chain L: GO:0000074, GO:0003809, GO:0004252, GO:0004263, GO:0004295, GO:0005102, GO:0005509, GO:0005576, GO:0005615, GO:0005625, GO:0006508, GO:0006915, GO:0006919, GO:0006953, GO:0007260, GO:0007262, GO:0007275, GO:0007596, GO:0008236, GO:0009611, GO:0016787, GO:0030168, GO:0030193, GO:0042730 | ||||||||||||||
disease | Dysprothrombinemia Hyperprothrombinemia Hypoprothrombinemia Thrombophilia due to heparin cofactor II deficiency Myocardialinfarction,susceptibility to Thrombophilia due to thrombomodulin defect Hcf-ii deficiency is a form of thrombophilia [mim. 188050], an autosomal dominant disorder in which affected individuals are prone to develop serious spontaneous thrombosis. Defects in f2 are the cause of various forms of dysprothrombinemia [mim. 176930]. Defects in serpind1 are the cause of heparin cofactor ii deficiency (hcf-ii deficiency) [mim. 142360, 188050]. | ||||||||||||||
Primary reference | Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism., Baglin TP, Carrell RW, Church FC, Esmon CT, Huntington JA, Proc Natl Acad Sci U S A 2002 Aug 20;99(17):11079-84. PMID:12169660 |
Data retrieval |
View 1JMO in 3D |
|
Visual 3D analysis of 1JMO |
|
Structure-derived information |
- Domain d1jmoa_, region A [Jmol] [rasmolscript] [script source] - Domain d1jmo.1, region L:,H [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1JMO |
Movements, Movies and Images |